Table 5. | Characteristics of studies included in systematic review, secondary bleeding, other complications and inhibitors |
| Study |
Secondary bleeding and additional therapy |
Other complications |
Presence of inhibitors |
|---|---|---|---|
| Peisker et al. [3] | 1 patient | 1 | 0 |
| Cocero et al. [5] | 5 patients | 0 | 2 |
| Kazancıoğlu et al. [12] | 2 patients | 0 | 2 |
.png)
.png)
.png)
.png)